NCT01209195 - A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions

Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,Primary Peritoneal Cancer or Endometrial CancerLocally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer

Interventions

DRUG

MM-121

increasing doses of MM-121 IV QW

DRUG

Paclitaxel

Paclitaxel - 80 mg/m2 IV QW

Trial Locations (5)

35294

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

85258

Pinnacle Oncology Hematology, Scottsdale

93309

Comprehensive Blood and Cancer Center, Bakersfield

93720

Cancer Care Associates of Fresno, Fresno

02115

Dana-Farber Cancer Institute, Boston